CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chongqing Taiji Industry (Group) Company Snapshot
Chongqing Taiji Industry (Group) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Taiji Industry (Group) with three other companies in this sector in China: Harbin Pharmaceutical Group Company Limited (2018 sales of 10.81 billion Chinese Renmimbi [US$1.53 billion] of which 65% was Medicine Trade), Huapont Life Sciences Co Ltd (10.57 billion Chinese Renmimbi [US$1.49 billion] of which 65% was Agricultural Business), and Xin Jiang Ready Health Industry Co Ltd (10.84 billion Chinese Renmimbi [US$1.53 billion] of which 86% was Pharmaceutical - Wholesale).

Sales Analysis. During the year ended December of 2018, sales at Chongqing Taiji Industry (Group) were 10.69 billion Chinese Renmimbi (US$1.51 billion). This is an increase of 22.4% versus 2017, when the company's sales were 8.73 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Chongqing Taiji Industry (Group) (and since 2013, sales have increased a total of 62%). Sales of Service saw an increase that was more than double the company's growth rate: sales were up 319.8% in 2018, from 12.06 million Chinese Renmimbi to 50.63 million Chinese Renmimbi. Chongqing Taiji Industry (Group) also saw significant increases in sales in Industrial (up 43.2% to 7.91 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chongqing Taiji Industry (Group)
  Stock Performance Chart for Chongqing Taiji Industry (Group)
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 12.61
(Figures in Chinese Renmimbi)
1 Week 4.0%   13 Weeks 7.0%  
4 Weeks 18.6%   52 Weeks 23.3%  
 
Chongqing Taiji Industry (Group) Key Data:
  Ticker: 600129 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 10,686,811,297
(Year Ending Jan 2019).
Employees: 13,494
  Currency: Chinese Renmimbi Market Cap: 7,022,392,282
  Fiscal Yr Ends: December Shares Outstanding: 556,890,744
  Share Type: A Gu Closely Held Shares: 269,445,196
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.